GET THE APP

Myelin Damage Innovations | Open Access Journals
Neurological Disorders

Neurological Disorders

ISSN: 2329-6895

Open Access

Myelin Damage Innovations

MS is a chronic disease that affects approximately 2.3 million people worldwide. In MS, the sheath covering the nerve fibers of the brain and spinal cord is damaged, slowing or preventing electrical signals from reaching the eyes, muscles and other parts of the body. This sheath is called myelin. Although myelin can grow back through exposure to thyroid hormones, researchers did not continue thyroid hormone therapy due to unacceptable side effects. Although there are many treatments and medications that reduce symptoms of MS, there is no cure. "Myelinate demyelinated axons and nerve fibers, and ours does," "It could have a significant impact on patients weakened by MS," said Bourdette. The discovery, if ultimately proven in clinical trials involving people, seems to achieve two important goals:

Repairing myelin with minimal side effects: The study showed that the compound - known as sobetiroma - promotes remylenation without the serious side effects of thyroid hormone therapy. Thyroid hormone therapy has not been tried in people because high chronic exposure known as hyperthyroidism damages the heart, bones and skeletal muscles.

Effective childbirth: researchers have developed a new derivative of sobetiroma (Sob-AM2) which penetrates the blood-brain barrier, thereby increasing the infiltration of the central nervous system

High Impact List of Articles
Conference Proceedings

Relevant Topics in Neuroscience & Psychology

Google Scholar citation report
Citations: 1343

Neurological Disorders received 1343 citations as per Google Scholar report

Neurological Disorders peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward